Please assess the completion status of the following clinical trial:

Trial Title: A Study for Patients With Complicated Skin and Skin Structure Infections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria~* Complicated skin and skin structure infection, presumed or proven to be caused by gram-positive pathogen(s).~* Patients, ages 18 years and older, must not be below normal body weight or morbidly obese.~* Female patients must not be pregnant at time of enrollment and must agree to a reliable method of birth control during the study and for 6 months following the last dose of study drug.~Exclusion Criteria:~Patients:~* with a condition which would prevent performing protocol safety and efficacy assessments.~* who have received antibiotics for more than 24 hours within the last 3 days.~* with an infection involving deep tissues or unlikely to be caused by gram positive bacteria~* who are nursing and will not stop nursing for at least 6 months~* with a prior allergic reaction to glycopeptides (e.g. vancomycin)~* with any of the following:~  1. toxic shock syndrome or toxic-like syndrome~ 2. presumed or proven infection caused by Clostridium species~ 3. bone infections~ 4. ischemic or gangrenous ulcers or wounds~ 5. infections caused only by gram-negative bacteria~ 6. infection of an artificial joint that cannot be removed~ 7. infection of the scrotum, perineum or perianal region~ 8. infection of a severe burn wound~ 9. severe ear infection involving bone and/or cartilage~ 10. infection following injury in water possibly containing Vibrio species or following a history of eating raw oysters within 1 week prior to disease onset

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None
- 3 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).